These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2440294)

  • 1. Animal pharmacology of nicardipine and its clinical relevance.
    Whiting RL
    Am J Cardiol; 1987 Jun; 59(17):3J-8J. PubMed ID: 2440294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of nicardipine on coronary blood flow.
    Pepine CJ; Lambert CR
    Am Heart J; 1988 Jul; 116(1 Pt 1):248-54. PubMed ID: 3293393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular effects of nicardipine.
    Pepine CJ; Lambert CR
    Angiology; 1990 Nov; 41(11 Pt 2):978-86. PubMed ID: 2248426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous nicardipine: cardiovascular effects and clinical relevance.
    Pepine CJ
    Clin Ther; 1988; 10(3):316-25. PubMed ID: 3078910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular action of nicardipine.
    Michel AD; Whiting RL
    Am J Cardiol; 1989 Oct; 64(15):3H-7H. PubMed ID: 2801573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacology, pharmacokinetics, and hemodynamic effects of nicardipine.
    Singh BN; Josephson MA
    Am Heart J; 1990 Feb; 119(2 Pt 2):427-34. PubMed ID: 1967896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nicardipine on exercise- and pacing-induced myocardial ischemia in angina pectoris.
    Lambert CR; Hill JA; Feldman RL; Pepine CJ
    Am J Cardiol; 1987 Sep; 60(7):471-6. PubMed ID: 3630928
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of nicardipine on determinants of myocardial ischemia occurring during acute coronary occlusion produced by percutaneous transluminal coronary angioplasty.
    Feldman RL; MacDonald RG; Hill JA; Pepine CJ
    Am J Cardiol; 1987 Aug; 60(4):267-70. PubMed ID: 2441586
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nicardipine on myocardial function in vitro and in vivo.
    Lambert CR; Buss DD; Pepine CJ
    Circulation; 1990 Feb; 81(2 Suppl):III139-47. PubMed ID: 2297878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicardipine, a new calcium channel blocker: role for vascular selectivity.
    Pepine C
    Clin Cardiol; 1989 May; 12(5):240-6. PubMed ID: 2656020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilatory properties in vascular smooth muscle of the calcium antagonist NB-818 compared to nicardipine and nimodipine.
    Nishikibe M; Fukuroda T; Nakajima A
    Arch Int Pharmacodyn Ther; 1989; 297():98-111. PubMed ID: 2730244
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamics of nicardipine in coronary artery disease.
    Visser CA; Koolen JJ; van Wezel H; Dunning AJ
    Am J Cardiol; 1987 Jun; 59(17):9J-12J. PubMed ID: 3300240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the new dihydropyridine derivative 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy)hexyl ester on the cardiohemodynamics and the energy metabolism of ischemic myocardium.
    Imai H; Matsui K; Ochi S; Nakazawa M; Nakagawa Y; Imai S
    Arzneimittelforschung; 1987 Dec; 37(12):1348-52. PubMed ID: 3449062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dihydropyridine calcium antagonist modulates cholesterol metabolism and eicosanoid biosynthesis in vascular cells.
    Nicholson AC; Etingin OR; Pomerantz KB; Summers BD; Friday K; Wolff AA; Hajjar DP
    J Cell Biochem; 1992 Apr; 48(4):393-400. PubMed ID: 1315789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.
    Freedman DD; Waters DD
    Drugs; 1987 Nov; 34(5):578-98. PubMed ID: 3319491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of UK-84149 on voltage-activated calcium currents of single smooth muscle cells from guinea-pig and rabbit jejunum and rabbit coronary artery.
    Zhang H; Bolton TB
    Br J Pharmacol; 1995 Apr; 114(8):1657-65. PubMed ID: 7599936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a newly synthesized K+ channel opener, Y-26763, on noradrenaline-induced Ca2+ mobilization in smooth muscle of the rabbit mesenteric artery.
    Itoh T; Ito S; Shafiq J; Suzuki H
    Br J Pharmacol; 1994 Jan; 111(1):165-72. PubMed ID: 8012692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nicardipine. A review of its pharmacology and therapeutic efficacy in older patients.
    Frampton JE; Faulds D
    Drugs Aging; 1993; 3(2):165-87. PubMed ID: 8477149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.